KROS icon

Keros Therapeutics
KROS

Overview Fund Activity

156 hedge funds and large institutions have $429M invested in Keros Therapeutics in 2025 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 48 increasing their positions, 40 reducing their positions, and 50 closing their positions.

Holders
156
Holders Change
-5
Holders Change %
-3.11%
% of All Funds
2.12%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
49
Increased
48
Reduced
40
Closed
50
Calls
$12.5M
Puts
$17M
Net Calls
-$4.54M
Net Calls Change
-$4.16M

Top Buyers

1
NL
1
Nuveen LLC
North Carolina
$94.5M
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$26.5M
3
LGM
3
Logos Global Management
California
$20.4M
4
ACM
4
ADAR1 Capital Management
Texas
$15.1M
5
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$12.9M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$4.5M
2
B
2
Braidwell
Connecticut
$0
3
DGM
3
Darwin Global Management
Jersey
$0
4
Holocene Advisors
4
Holocene Advisors
New York
$0
5
JFG
5
Jefferies Financial Group
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
NL
1
Nuveen LLC
North Carolina
$94.5M 3,947,455 +3,947,455 New
BlackRock
2
BlackRock
New York
$28.4M 2,785,237 +55,959 +2%
JPMorgan Chase & Co
3
JPMorgan Chase & Co
New York
$26.5M 2,600,457 +2,387,026 +1,118%
Vanguard Group
4
Vanguard Group
Pennsylvania
$26.2M 2,566,321 +609,212 +31%
LGM
5
Logos Global Management
California
$20.4M 2,000,000 +2,000,000 New
Morgan Stanley
6
Morgan Stanley
New York
$17.3M 1,697,557 +1,040,756 +158%
NCM
7
Nantahala Capital Management
Connecticut
$15.4M 1,506,790 +591,742 +65%
ACM
8
ADAR1 Capital Management
Texas
$15.1M 1,486,461 +1,463,215 +6,294%
State Street
9
State Street
Massachusetts
$13.3M 1,302,539 +99,156 +8%
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
$12.9M 1,263,130 +1,251,031 +10,340%
Federated Hermes
11
Federated Hermes
Pennsylvania
$12.5M 1,224,139 +1,099,519 +882%
TCM
12
Tang Capital Management
California
$11.2M 1,100,000 +1,100,000 New
O
13
OrbiMed
New York
$10.4M 1,018,734 – –
Alkeon Capital Management
14
Alkeon Capital Management
New York
$8.67M 850,511 -250,489 -23%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$8.22M 806,185 +40,749 +5%
Goldman Sachs
16
Goldman Sachs
New York
$7.55M 740,606 +205,022 +38%
RG
17
Redmile Group
California
$5.63M 552,506 – –
DS
18
DRW Securities
Illinois
$4.74M 464,895 +464,895 New
Fidelity Investments
19
Fidelity Investments
Massachusetts
$4.5M 441,540 -5,101,768 -92%
RC
20
Rangeley Capital
Connecticut
$4.16M 408,234 +408,234 New
CCM
21
Catalio Capital Management
New York
$3.97M 389,384 -17,908 -4%
Northern Trust
22
Northern Trust
Illinois
$2.96M 290,011 -6,456 -2%
PP
23
PDT Partners
New York
$2.81M 276,060 +276,060 New
IC
24
Ikarian Capital
Texas
$2.79M 274,009 +274,009 New
Qube Research & Technologies (QRT)
25
Qube Research & Technologies (QRT)
United Kingdom
$2.79M 273,342 +273,342 New
1
2 3 4 5